ImmuPharma plc (AIM:IMM)
1.618
+0.098 (6.41%)
Aug 15, 2025, 4:35 PM GMT+1
ImmuPharma Employees
ImmuPharma had 6 employees as of December 31, 2024. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-655.75K GBP
Market Cap
8.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Oxford Nanopore Technologies | 1,382 |
HUTCHMED (China) | 1,811 |
ImmuPharma News
- 10 days ago - AIM Market Roundup: Catenai, Europa Oil & Gas, Faron Pharma - The Armchair Trader
- 10 days ago - FTSE Rises as Investors Eye Tariff Deadline - Investomania
- 5 months ago - FX positioning info - Net speculative EUR longs surged in a sharp rise from previous week - Forexlive
- 5 months ago - Data show speculative traders have flipped from a net short to a net long position on euro - Forexlive
- 7 months ago - AIM Market Roundup: Immupharma, Poolbeg, Xeros - The Armchair Trader
- 1 year ago - Three Quick Facts: Norman Broadbent, Computacenter, Immupharma - The Armchair Trader